Crinetics Pharmaceuticals EBITDA 2017-2024 | CRNX
- Crinetics Pharmaceuticals 2023 EBITDA was -0.228B, a 36.51% increase from 2022.
- Crinetics Pharmaceuticals 2022 EBITDA was -0.167B, a 56.89% increase from 2021.
- Crinetics Pharmaceuticals 2021 EBITDA was -0.106B, a 43.28% increase from 2020.
EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.